We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Advanced 3-D X-Ray Imaging Provides Insight into the Progression of Idiopathic Pulmonary Fibrosis

By MedImaging International staff writers
Posted on 02 May 2016
Print article
Researchers have used a novel and advanced 3D Computer Tomography (CT) imaging technique to follow the development of an aggressive deadly lung disease called Idiopathic Pulmonary Fibrosis (IPF).

IPF is currently diagnosed using 2D CT scans or by taking a lung biopsy in hospital for investigation under an optical microscope. The new technique, originally designed for aircraft engineering, is used to carry out 3D scans of lung biopsy samples at a resolution similar to that of an optical microscope.

The team from the UK National Institute for Health Research Southampton Respiratory Biomedical Research Unit (BRU), University of Southampton (Southampton, UK) used CT equipment at the µ-VIS Centre for Computed Tomography (Southampton, UK) to perform the Microfocus CT scans. The scan technique involves rotating the biopsy sample 360 degrees while making numerous 2D images, which are rendered into detailed 3D images.

The results of the research were published in the April 21, 2016, issue of the journal JCI Insight. The incidence of IPF in the UK is increasing by 5% every year. In 2015 more than 5,000 new cases were diagnosed in the UK. One of the symptoms of patients with IPF, an interstitial lung disease, is difficulty breathing. The disease causes inflammation, and scarring of lung tissue, and patients have a life expectancy of between three and five years.

Lead author of the study, Dr. Mark Jones, University of Southampton, said, “Whilst accurate diagnosis of IPF is essential to start the correct treatment, in certain cases this can be extremely challenging to do using the tools currently available. This technology advance is very exciting as for the first time it gives us the chance to view lung biopsy samples in 3D. We think that the new information gained from seeing the lung in 3D has the potential to transform how diseases such as IPF are diagnosed. It will also help to increase our understanding of how these scarring lung diseases develop which we hope will ultimately mean better targeted treatments are developed for every patient.”

Related Links:
UK National Institute for Health Research Southampton Respiratory Biomedical Research Unit (BRU), University of Southamptonµ-VIS Centre for Computed Tomography
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Self-Driving Mobile C-arm
CIARTIC Move
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.